Literature DB >> 7905464

Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection.

S A Aguirre1, P H Mason, L E Perryman.   

Abstract

Major histocompatibility complex (MHC) class I-deficient and MHC class II-deficient mice lack functional CD8 T cells and CD4 T cells, respectively. These mice were evaluated for infection following oral administration of 10(7) Cryptosporidium parvum oocysts. MHC class II-deficient (but not MHC class I-deficient) mice dosed with C. parvum oocysts at 3 to 5 days of age remained infected 8 weeks postexposure. MHC class II-deficient mice exposed to C. parvum oocysts at 5 to 6 weeks of age were significantly more susceptible to infection than control mice (P < 0.0001).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7905464      PMCID: PMC186160          DOI: 10.1128/iai.62.2.697-699.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

Review 1.  Cryptosporidium spp. and cryptosporidiosis.

Authors:  R Fayer; B L Ungar
Journal:  Microbiol Rev       Date:  1986-12

2.  IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

Authors:  M Sarmiento; A L Glasebrook; F W Fitch
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

Review 3.  Human cryptosporidiosis.

Authors:  F G Crawford; S H Vermund
Journal:  Crit Rev Microbiol       Date:  1988       Impact factor: 7.624

4.  B lymphocyte development and activation independent of MHC class II expression.

Authors:  J S Markowitz; P R Rogers; M J Grusby; D C Parker; L H Glimcher
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

5.  Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines.

Authors:  D B Wilde; P Marrack; J Kappler; D P Dialynas; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

6.  Infectivity and neutralization of Cryptosporidium parvum sporozoites.

Authors:  M W Riggs; L E Perryman
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

Review 7.  Cryptosporidiosis: clinical, epidemiologic, and parasitologic review.

Authors:  T R Navin; D D Juranek
Journal:  Rev Infect Dis       Date:  1984 May-Jun

Review 8.  Cryptosporidium and cryptosporidiosis.

Authors:  R Soave; D Armstrong
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

9.  Persistent Cryptosporidium infection in congenitally athymic (nude) mice.

Authors:  J Heine; H W Moon; D B Woodmansee
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

10.  Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission.

Authors:  W L Current; N C Reese; J V Ernst; W S Bailey; M B Heyman; W M Weinstein
Journal:  N Engl J Med       Date:  1983-05-26       Impact factor: 91.245

View more
  31 in total

1.  CD4+ T cells are not essential for control of early acute Cryptosporidium parvum infection in neonatal mice.

Authors:  Daniel S Korbel; Farah M Barakat; James P Di Santo; Vincent McDonald
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

Review 2.  Intestinal immune response to human Cryptosporidium sp. infection.

Authors:  Birte Pantenburg; Sara M Dann; Heuy-Ching Wang; Prema Robinson; Alejandro Castellanos-Gonzalez; Dorothy E Lewis; A Clinton White
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

3.  Human CD8(+) T cells clear Cryptosporidium parvum from infected intestinal epithelial cells.

Authors:  Birte Pantenburg; Alejandro Castellanos-Gonzalez; Sara M Dann; Rhykka L Connelly; Dorothy E Lewis; Honorine D Ward; A Clinton White
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

Review 4.  The immunology of parasite infections in immunocompromised hosts.

Authors:  T Evering; L M Weiss
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

5.  Recombinant proteins of Cryptosporidium parvum induce proliferation of mesenteric lymph node cells in infected mice.

Authors:  Inderpal Singh; Cynthia Theodos; Saul Tzipori
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Localization of alpha/beta and gamma/delta T lymphocytes in Cryptosporidium parvum-infected tissues in naive and immune calves.

Authors:  M S Abrahamsen; C A Lancto; B Walcheck; W Layton; M A Jutila
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

7.  Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins.

Authors:  Maria Angeles Gomez Morales; Raffaella Mele; Alessandra Ludovisi; Fabrizio Bruschi; Fabio Tosini; Rachele Riganò; Edoardo Pozio
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Cryptosporidium parvum initiates inflammatory bowel disease in germfree T cell receptor-alpha-deficient mice.

Authors:  R E Sacco; J S Haynes; J A Harp; W R Waters; M J Wannemuehler
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

Review 9.  CD40 and the immune response to parasitic infections.

Authors:  Carlos S Subauste
Journal:  Semin Immunol       Date:  2009-07-18       Impact factor: 11.130

10.  Induced susceptibility of host is associated with an impaired antioxidant system following infection with Cryptosporidium parvum in Se-deficient mice.

Authors:  Chengmin Wang; Yanyun Wu; Jianhua Qin; Haoxue Sun; Hongxuan He
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.